NCT01639911 2019-07-22Phase I Study of MLN8237 and Pazopanib in Patients With Solid TumorsUniversity of Illinois at ChicagoPhase 1 Completed28 enrolled
NCT01540682 2018-08-29MLN8237 in Head and Neck CancerAbramson Cancer Center at Penn MedicinePhase 1 Completed9 enrolled